While so much of the medical community has focused its attention on treating and caring for patients with the coronavirus disease 2019 (COVID-19), the unfortunate truth is that the need for quality and compassionate cancer care continues.
Mike Hennessy Sr
The treatment landscape for breast cancer continues to evolve at an accelerating pace. Because of an expanding arsenal of targeted therapies, survival rates are increasing, and patients are living longer and more meaningful lives.
While the development of immunotherapy and targeted agents has advanced treatment options for a variety of malignancies, there is still the reminder that not all regimens work in treating cancer.